This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Smokeless Unit Help Altria Pare Low Cigarette Sales?
by Zacks Equity Research
Altria (MO) is undertaking efforts to expand in the RRPs space amid receding cigarette shipping volumes.
Big Tobacco Takes a Big Hit (MO) (PM) (BTI) (Revised)
by Zachary Stutler
Since Friday, Altria Group Inc. (MO), Philip Morris International Inc. (PM), and British American Tobacco PLC (BTI) have all fallen 5.1%, 5.9%, and 5.7% respectively as of market close on Wednesday, May 29. And opened Thursday with very little change.
Big Tobacco Takes a Big Hit (MO) (PM) (BTI)
by Zachary Stutler
Since Friday, Altria Group Inc. (MO), Philip Morris International Inc. (PM), and British American Tobacco PLC (BTI) have all fallen 5.1%, 5.9%, and 5.7% respectively as of market close on Wednesday, May 29. And opened Thursday with very little change.
Will Pricing & RRPs Aid Altria's (MO) Q1 Earnings Growth?
by Zacks Equity Research
Altria's (MO) Q1 performance is likely to gain from RRPs and high pricing. However, receding cigarette sales are a concern.
Is British American Tobacco (BTI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will RRPs & Pricing Drive Philip Morris' (PM) Q1 Earnings?
by Zacks Equity Research
Philip Morris' (PM) Q1 performance to gain from high pricing and advancements in RRPs. However, declining cigarette volumes are a worry.
Altria to Boost Interests in JUUL, Aims to Gain Voting Rights
by Zacks Equity Research
Altria (MO) provides information related to investment in JUUL to the FTC. It seeks to gain voting interests in JUUL.
Philip Morris' (PM) Year of Unsmoke Underscores Focus on RRPs
by Zacks Equity Research
Philip Morris (PM) is benefiting from focus on reduced-risk products, which is reconfirmed by its latest launch of "The Year of Unsmoke."
Is British American Tobacco p.l.c. (BTI) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (BTI) Outperforming Other Consumer Staples Stocks This Year?
BTI vs. JAPAY: Which Stock Is the Better Value Option?
by Zacks Equity Research
BTI vs. JAPAY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
5 Consumer Staples Stocks for an Era of Soft Yields
by Swarup Gupta
Consumer staples are smart choices during a period of soft long-term rates, which signal a near-term economic slowdown.
Is British American Tobacco (BTI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Philip Morris Looks Alluring on Gains from RRPs & Pricing
by Zacks Equity Research
Philip Morris (PM) is progressing well with bolstering presence in the low-risk tobacco space. Further, the company's pricing strategies are yielding results.
Altria (MO) Hurt by Low Cigarette Sales, Inclines Toward RRPs
by Zacks Equity Research
Altria (MO) is undertaking efforts to expand in the RRPs space amid receding cigarette shipping volumes.
Has British American Tobacco p.l.c. (BTI) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (BTI) Outperforming Other Consumer Staples Stocks This Year?
Top Ranked Momentum Stocks to Buy for March 19th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 19th
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
Is Britain Headed for a Soft Brexit? 5 Picks
by Swarup Gupta
Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.
Top Ranked Income Stocks to Buy for March 14th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 14th:
Is British American Tobacco (BTI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Altria Focuses on RRPs Growth, Closes Investment in Cronos
by Zacks Equity Research
Altria (MO) closes investment deal in Cronos Group. The move is in sync with the company's efforts to expand in the smokeless category.
Is British American (BTI) a Good Pick for Value Investors?
by Zacks Equity Research
British American Tobacco (BTI) stock may be a good choice for value-oriented investors right now.
Top Ranked Income Stocks to Buy for March 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 6th
British American (BTI) 2018 Earnings: Pricing a Key Catalyst
by Zacks Equity Research
British American's (BTI) preliminary 2018 results to gain from robust pricing as well as growth in low-risk tobacco products.